Viewing Study NCT00864604


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-02-24 @ 5:08 AM
Study NCT ID: NCT00864604
Status: COMPLETED
Last Update Posted: 2020-01-07
First Post: 2009-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Dose Two-Way Crossover Fed Bioequivalence Study of Nabumetone 750 mg Tablets in Healthy Volunteers
Sponsor: Actavis Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bioequivalence View
None Nabumetone View
None Healthy subjects View